EFFECT OF 4-VINYLCYCLOHEXENE ON MICRONUCLEUS FORMATION IN THE BONE MARROW OF RATS AND MICE

REFERENCES

• International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol.60 Some Industrial Chemicals, Lyon. 1994, 3477–359
   Google Scholar
• Rappaport S., Fraser D. Gas chromatographic-mass spectrophotometric identification of volatiles released from a rubber stock during simulated vulcanization. Anal. Chem. 1976; 48: 476–481
   Web of Science ®Google Scholar
• Bevan C., Stadler J. C., Elliott G. S., Frame S. R., Baldwin J. K., Leung H.-W., Moran E., Panepinto A. S. Subchronic toxicity of 4-vinylcyclohexene in rats and mice by inhalation exposure. Fundam. Appl. Toxicol. 1996; 32: 1–10
   PubMedGoogle Scholar
• Collins J. J., Manus A. G. Toxicological evaluation of 4-vinylcyclohexene. I. Prechronic (14-day) and subchronic (13-week) gavage studies in Fischer 344 rats and B6C3F1mice. J. Toxicol. Environ. Health 1987; 21: 493–505
   PubMed Web of Science ®Google Scholar
• Collins J. J., Montali R. J., Manus A. G. Toxicological evaluation of 4-vinylcyclohexene. II. Induction of ovarian tumors in female B6C3F1by chronic oral administration of 4-vinylcyclohexene. J. Toxicol. Environ. Health 1987; 21: 507–524
   PubMed Web of Science ®Google Scholar
• U.S. EPA. Testing Consent Order for 4-Vinylcyclohexene. Federal Register 1991; 56(184)47912–47915
   Google Scholar
• Gervasi P G, Abbondandolo A., Citti L., Turchi G. Microsomal 4-vinylcyclohexene monooxygenase and mutagenic activity of metabolic intermediates. In Proc. Int. Conf. Indust. Environ. Xenobiotics: Biotransformation and Pharmacokinetics, I. Gut. Springer-Verlag, Berlin 1980; 205–210
   Google Scholar
• Watabe T., Hiratsuka A., Ozawa N., Isobe M. A comparative study on the metabolism of d-limonene and 4-vinylcyclohex-1-ene by hepatic microsomes. Xenobiotica 1981; 11: 333–344
   PubMed Web of Science ®Google Scholar
• Keller D A, Carpenter S C, Cagen S Z, Reitman F A. In vitro metabolism of 4-vinylcyclohexene in rat and mouse liver, lung, and ovary. Toxicol. Appl. Pharmacol. 1997; 144: 36–44
   PubMed Web of Science ®Google Scholar
• Himmelstein M W, Acquavella J F, Recio L., Medinsky M A, Bond J A. Toxicology and epidemiology of 1,3-butadiene. Crit. Rev. Toxicol. 1997; 27: 1–108
   PubMed Web of Science ®Google Scholar
• Zeiger E., Anderson B., Haworth S., Lawlor T., Mortelsman K., Speck W. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ. Mut. 1987; 9: 1–110
   PubMedGoogle Scholar
• US Department of Health and Human Services. Report No. 10-330-89, 1989. NTP. National Toxicology Program. Research Triangle Park, NC: National Toxicology Program/National Institute of Environmental Health Sciences
   Google Scholar
• International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 71. Re-evaluation of Some Organic ChemicalsHydrazine and Hydrogen Peroxide, Lyon, 1999
   Google Scholar
• Crouch C., Pullinger D H, Gaunt I F. Inhalation toxicity studies with 1,3-butadiene. 2. 3-month toxicity study in rats. Am. Ind. Hyg. Assoc. J. 1979; 40: 796–802
   PubMed Web of Science ®Google Scholar
• NTP. Toxicology and Carcinogenesis Studies of 1,3-Butadiene in B6C2F1 Mice(Inhalation Studies), National Toxicology Program. TR 288. U.S. Department of Health and Human Services, National Institutes of Health 1984
   Google Scholar
• Irons R D, Smith C N, Stillman W S, Shah R S, Steinhagen W H, Leiderman L J. Macrocytic-megaloblastic anemia in male B6C6F1 mice following repeated exposure to 1,3-butadiene. Toxicol. Appl. Pharmacol. 1986; 85: 95–100
   Google Scholar
• Owen P E, Glaister J R, Gaunt I F, Pullinger D H. Inhalation toxicity studies with 1,3-butadiene 3, two year toxicity/carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J. 1987; 48: 476–413
   Google Scholar
• Cunningham M J, Choy W N, Arce G T, Rickard L B, Vlachos D A, Kinney L A, Sarif A M. In vivo sister chromatid exchange and micronucleus induction studies with 1,3-butadiene in B6C3F1mice and Sprague-Dawley rats. Mutagenesis 1986; 1: 449–452
   PubMed Web of Science ®Google Scholar
• Tice R R, Boucher R., Luke C A, Shelby M D. Comparative cytogenetic analysis of bone marrow damage induced in male B6C3F1male mice by multiple exposures to gaseous 1,3-butadiene. Environ. Mutagen. 1987; 9: 235–250
   PubMedGoogle Scholar
• Heddle J A, Hite M., Kirkhart B., Mavournin K., MacGregor J T, Newell G W, Salamone M F. The induction of micronuclei as a measure of genotoxicity. a report of the U.S. Environmental Protection Agency genotox program. Mutat. Res. 1983; 123: 61–118
   PubMed Web of Science ®Google Scholar
• Himmelstein M W, Asgharian B., Bond J A. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Toxicol. Appl. Pharmacol. 1995; 132: 281–288
   PubMed Web of Science ®Google Scholar
• Jauhar P P, Henika P R, MacGregor M T, Wehr C M, Shelby M D, Murphy S A, Margolin B H. 1,3-Butadiene: induction of micronucleated erythrocytes in the peripheral blood of B6C3F1mice exposed by inhalation for 13 weeks. Mutat. Res. 1988; 209: 171–176
   PubMed Web of Science ®Google Scholar
• Autio K., Renzi L., Catalan J., Albrecht O E, Sorsa M. Induction of micronuclei in peripheral blood and bone marrow erythrocytes of rats and mice exposed to 1,3-butadiene by inhalation. Mutat. Res. 1994; 309: 315–320
   PubMed Web of Science ®Google Scholar
• Smith B J, Mattison D R, Sipes I G. The role of epoxidation in 4-vinylcyclohexene-induced ovarian toxicity. Toxicol. Appl. Pharmacol. 1990; 105: 372–381
   PubMed Web of Science ®Google Scholar
• Smith B J, Carter D E, Sipes I G. Comparison of the disposition and in vitro metabolism of 4-vinylcyclohexene in the female mouse and rat. Toxicol.Appl. Pharmacol 1990; 105: 364–371
   PubMed Web of Science ®Google Scholar
• Csanády G. A., Guengerich R P, Bond J. A. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 1992; 13: 1143–1153
   PubMed Web of Science ®Google Scholar
• Thorton-Manning J R, Dahl A. R., Bechtold W E, Griffith W C, Henderson R F. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 1995; 16: 1723–1732
   Google Scholar
• Hooser S B, Parola L R, Van Ert M D, Sipes I.G. Differential ovotoxicity of 4-vinylcyclohexene and its analog, 4-phenylcyclohexene. Toxicol. Appl. Pharmacol. 1993; 119: 302–305
   PubMed Web of Science ®Google Scholar
• Doerr J K, Hooser S B, Smith B J, Sipes I G. Ovarian toxicity of 4-vinylcyclohexene and related olefins in B6C3F1mice: role of diepoxides. Chem. Res. Toxicol 1995; 8: 963–969
   PubMed Web of Science ®Google Scholar
• Okey A B. Enzyme induction in the cytochrome P-450 system. Pharmacol. Ther. 1989; 45: 241–298
   Web of Science ®Google Scholar
• U.S. EPA. EPA Environmental Protection Agency. Toxic Substances Control Act Good Laboratory Practice (GLP). Final Rule. Federal Register 1989; 54: 34033–34050
   Google Scholar